88
Views
25
CrossRef citations to date
0
Altmetric
Review article

Primary lateral sclerosis, hereditary spastic paraplegia, and mutations in the alsin gene: Historical background for the first International Conference

Pages 67-76 | Accepted 07 Mar 2005, Published online: 10 Jul 2009

References

  • Ince PG, Evans J, Knopp M, Forster G, Hamdalla HH, Wharton SB, Shaw PJ. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology. 2003 Apr;60:1252–8.
  • Lawyer T, Netsky MG. ALS. Clinico-anatomic study of 53 cases. Arch Neurol Psychiatry. 1953;69:171–92.
  • Brownell B, Oppenheimer DR, Hughes JT. Central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry. 1970;33:338–57.
  • Leung DK, Hays AP, Karlikaya G, Del Bene ML, Rowland LP. Diagnosis of ALS: clinicopathologic analysis of 76 autopsies. Neurology. 1999;52:A164.
  • Piao YS, Wakabayashi K, Kakita A, Yamada M, Hayashi S, Morita T, et al. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol. 2003;13:10–22.
  • Gastaut JL, Michel B, Figarella-Branger D, Somma- Mauvais H. Chronic progressive spinobulbar spasticity. A rare form of primary lateral sclerosis. Arch Neurol. 1988;45:509–13.
  • Charcot J-M. Scle`rose des cordons late e`rale de la moelle e e`pinie`re chez une femme hyste´rique, atteinte de contracture permanente des quatre members. Bull Me´m Soc Me´d Hoˆp Paris, 2nd series, 1865;2:24–42.
  • Erb W. U¨ ber einen wenig bekannten spinalen Symptomencomplex. Berl Klin Wschr. 1875;12:357–9.
  • Charcot J-M. De la scle`rose amyotrophique late´rale. Prog Med. 1874;2:325–7,341–2, 453–5.
  • Rowland LP. How amyotrophic lateral sclerosis got its name. The clinical-pathologic genius of Jean-Martin Charcot. Arch Neurol. 2001;58:512–5.
  • Erb W. Spastic and syphilitic spinal paralysis. Lancet. 1902;2:969–74.
  • Pearce JM. Primary lateral sclerosis and Pierre Marie. J Neurol Neurosurg, Psychiatry. 2004;75:897.
  • Marie P. Lec¸ons sur les maladies de la moelle. Paris, Masson 1892. Paris, Masson 1892. English translation Montagu Lubbock, London: The New Sydenham Society, 1895, Vol CLII(page 84), 1895.
  • Spiller WG. Primary degeneration of the pyramidal tracts: a study of eight cases. Univ Pa Med Bull. 1904;17:390–5.
  • Buzzard EF, Barnes S. A case of chronic progressive double hemiplegia. Rev Neurol Psychiatry. 1906;4:182–91.
  • Imai H, Furukawa Y, Summino S, Mori H, Ueda G, Shirai T, et al. A 65-year-old female with dysarthria, dysphagia, weakness, and gait disturbance. (Japanese; English abstract). No To Shinkei. 1995;47:399–410.
  • Kato S, Hirano A, Liena JF. Primary lateral sclerosis; a case report (in Japanese, abstract in English). Shinkeinaika. 1990;32:501–6. Cited by Watanabe.
  • Konagaya M, Sakai M, Iida M, Hashizume Y. An autopsied case of dominantly affecting upper motor neuron with atrophy of frontal and temporal lobes; with special reference to primary lateral sclerosis (in Japanese). Rhinshoshinkeigaku. 1995;35:384–90. Cited by Watanabe.
  • Caselli RJ, Smith BE, Osborne D. Primary lateral sclerosis: a neuropsychological study. Neurology. 1995;45:2005–9.
  • Zhai P, Pagan F, Statland J, Butman JA, Floeter MK. Primary lateral sclerosis: a heterogeneous disorder composed of different subtypes? Neurology. 2003;60:1258–65.
  • Heene R, Kolander D, Knisatschek H. Chronic progressive spinobulbar spasticity (primary lateral sclerosis). Fortschr Neurol Psychiatr. 1996;64:192–203. [In German].
  • Wechsler IS, Brody S. The problem of primary lateral sclerosis. JAMA. 1946;130:1196–8.
  • Merritt HM, Discussion of reference 19, page 1198.
  • Wilson SAK, Bruce AN. Neurology. Baltimore: Williams & Wilkins; 1940. vol 2, 1015–7.
  • Stark FM, Moersch FP. Primary lateral sclerosis. J Nerv Ment Dis. 1945;102:332–7.
  • Fisher CM. Pure spastic paralysis of corticospinal origin. Can J Neurol Sci. 1977;4:251–8.
  • Beal MF, Richardson EP. Primary lateral sclerosis: a case report. Arch Neurol. 1981;38:630–3.
  • Kuzuhara S, Namura H, Inomasta H, Toyokura Y, Tomonaga A. A case with marked atrophy in the fronto- temporal lobe similar to Pick’s disease in addition to the clinical as well as pathological features of primary lateral sclerosis (In Japanese). Shinkeibyouigaku. Neuropathology. 1985;6:295–6.Cited by Watanabe.
  • Kato S, Hirano A, Liena JF. Primary lateral sclerosis; a case report (in Japanese, abstract in English). Shinkeinaika. 1990;32:501–6. Cited by Watanabe.
  • Younger DS, Chou S, Hays AP, Lange DJ, Emerson R, Brin M, et al. Primary lateral sclerosis: a clinical diagnosis reemerges. Arch Neurol. 1988;45:1304–7.
  • Reyes-Iglesias Y, Melendez-Feliciano R, Garayalde-Cotroneo G, Noriega-Sanchez A. Primary lateral sclerosis: a distinct clinical entity in patients with chronic spastic paraparesis. Bol Asoc Med P R;82:340–2.
  • Forsyth PA, Dalmau J, Graus F, Cwik V, Rosenblum MK, Posner JB. Motor neuron syndromes in cancer patients. Ann Neurol. 1997;41:722–30.
  • Rowland LP. Paraneoplastic primary lateral sclerosis and amyotrophic lateral sclerosis. Ann Neurol. 1997;41:703–5.
  • Corcia P, Honnorat J, Guennoc AM, Toffol B, Autret A. Primary lateral sclerosis with breast cancer, a potential paraneoplastic neurological syndrome. Rev Neurol (Paris). 2000;156:1020–2 [In French].
  • Desai J, Swash M. IgM paraproteinemia in a patient with primary lateral sclerosis. Neuromuscul Disord. 1999;9:38–40.
  • Hainfellner JA, Pilz P, Lassmann H, Ladurner G, Budka H. Diffuse Lewy body disease as substrate of primary lateral sclerosis. J Neurol. 1995;242:59–63.
  • Kuipers-Upmeijer J, de Jager AE, Hew JM, Snoek JW, van Weerden TW. Primary lateral sclerosis: clinical, neurophy- siological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry. 2001;71:615–20.
  • Le Forestier N, Maisonobe T, Piquard A, Rivaud S, Crevier-Buchman L, Salachas F, et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain. 2001;124:1989–99.
  • Le Forestier N, Maisonobe T, Spelle L, Lesort A, Salachas F, Lacomblez L, et al. Primary lateral sclerosis; further clarification. J Neurol Sci. 2001;185:96–100.
  • Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain. 1992;115:495–520.
  • Bunina TL. On intracellular inclusion in familial amyo- trophic lateral sclerosis. Korsakov J Neuropathol Psychiatry. 1962;62:1293–9(In Russian).
  • Hart MN, Cancilla PA, Frommes S, Hirano A. Anterior horn cell degeneration and Bunina-type inclusions asso- ciated with dementia. Acta Neuropathol. 1977;38:225–8.
  • Hirano A, Inoue K. Early pathological changes of amyo- trophic lateral sclerosis: electron microscopic study of chromatolysis, spheroids, and Bunina bodies. Neurol Med. (Tokyo). 1980;13:148–60.
  • Leigh PN, Anderton BH, Dodson A, Gallo JM, Swash M, Power DM. Ubiquitin deposits in anterior horn cells in motor neuron disease. Neurosci Lett. 1988;93:197–203.
  • Lowe J, Lennox G, Jefferson D, Morrell K, McQuire D, Gray T, et al. A filamentous inclusion body within anterior horn neurons in motor neuron disease defined by immuno- cytochemical localization of ubiquitin. Neurosci Lett. 1988;93:203–10.
  • Kato T, Katagiri T, Hirano A, Kawanami T, Sasaki H. Lewy body-like hyaline inclusions in sporadic motor neuron disease are ubiquitinated. Acta Neuropathol. 1988;77:391–6.
  • Wightman G, Anderson VER, Martin J, Swash M, Anderton BH, Neary D, et al. Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett. 1992;139:269–74.
  • Caselli RJ, Windebank AJ, Petersen RC. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol. 1993;33:200–7.
  • Brun A, Englund B, Gustavson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994;57:416–8.
  • Wilhelmsen KC, Lynch T, Pavlou E, Higgins M, Nygaard TG. Localization of disinhibition-dementia Parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet. 1994;55:1159–65.
  • Wilhelmsen KC, Forman MS, Rosen HJ, Alving LI, Goldman J, Feiger J, et al. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without Tau muta- tions with tau and a-synuclein inclusions. Arch Neurol. 2004;61:398–406.
  • Kovari E, Leuba G, Savioz A, Saini K, Anastasiu R, Miklossy J, Bouras C. Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease. Acta Neuropathol. (Berl). 2000;100:421–6.
  • Uchihara T, Sato T, Suzuki H, Ikeda K, Akiyama H, Taktori T. Bunina body in frontal lobe dementia without clinical manifestations. Acta Neuropathol. 2001;101:281–4.
  • Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59:1077–9.
  • Lipton AM, White CL, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol. (Berl) 2004; (Epub ahead of print).
  • Yoshida M. Amyotrophic lateral sclerosis with dementia: the clinicopathological spectrum. Neuropathology. 2004;24:87–102.
  • Josephs KA, Holton JL, Rosser MN, Godbolt AK, Ozawa T, Strand K, et al. Frontotemporal lobar degeneration and ubiquitin histochemistry. Neuropathol Appl Neurobiol. 2004;30:369–73.
  • Mann DM, South PW, Snowden JS, Neary D. Dementia of the frontal lobe type; neuropathology and immunohisto- chemistry. J Neurol Neurosurg Psychiatry. 1993;56:605–14.
  • Paviour DC, Lees AJ, Josephs KA. Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes; broadening the clinical picture to include progres- sive supranuclear palsy. Brain 2004; [Epub ahead of print].
  • Josephs KA, Holton JL, Rossor MN, Braendgaard H, Ozawa T, Fox NC, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain. 2003;126:2291–303.
  • Frontotemporal and motor neuron degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol. 2003;29:239–53.
  • Mackenzie IR, Feldman H. Neurofilament inclusion body disease with early onset frontotemporal dementia and primary lateral sclerosis. Clin Neuropathol. 2004;23:183–93.
  • Zhai P, Pagan F, Statland J, Butman JA, Floeter MK. Primary lateral sclerosis: a heterogeneous disorder composed of different subtypes? Neurology. 2003;22:1258–65.
  • Bruyn RP, Koelman JH, Troost D, de Jong JM. Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry. 1995;58:742–4.
  • Le Forestier N, Maisonobe T, Spelle L, Lesort A, Salachas F, Lacomblez L, et al. Primary lateral sclerosis: further clarification. J Neurol Sci. 2001;185:95–100.
  • Le Forestier N, Maisonobe T, Piquard A, Rivaud S, Crevier-Buchman L, Salachas F, et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain. 2001;124:1989–99.
  • Strong MJ, Gordon PH. Primary lateral sclerosis, hereditary spastic paraplegia, and amyotrophic lateral sclerosis – discrete entities or spectrum? (In press.)
  • Watanabe R, Iino M, Honda M, Sano J, Hara M. Primary lateral sclerosis. Neuropathology. 1997;17:220–4.
  • Konagaya M, Sakai M, Matsuoka Y, Konagaya Y, Hashizume Y. Upper motor neuron predominant degenera- tion with frontal and temporal lobe atrophy. Acta Neuropathol. 1998;96:532–6.
  • Sugihara H, Horiuchi M, Kamo T, Fujisawa K, Abe M, Sakiyama T, et al. A case of primary lateral sclerosis taking a prolonged course with dementia and having an unusual dendritic ballooning. Neuropathology. 1999;19:77–84.
  • Tan C-F, Kakita A, Piao Y-S, Kikugawa K, Endo K, Tanaka M, et al. Primary lateral sclerosis: a rare upper- motor-neuron predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degen- eration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature. Acta Neuropath. 2003;105:615–20.
  • Koga H, Ozeki T, Makura Y, Nokara K, Yamamoto H, Matsumoto Y, et al. Sporadic motor neuron disease with marked frontotemporal atrophy: an autopsied case mimick- ing primary lateral sclerosis. Neuropathology. 2003;23:A40.
  • Mochizuki A, Komastsuzaki Y, Iwamoto H, Shoji S. Frontotemporal dementia with ubiquitinated neuronal inclusions presenting with primary lateral sclerosis and Parkinsonism; clinicopathological report of an autopsy case. Acta Neuropathol. 2004;107:377–80.
  • Engel PA, Grunnet M. Atypical dementia and spastic paraplegia in a patient with primary lateral sclerosis and numerous neocortical beta amyloid plaques: new disorder or Alzheimer’s disease variant? J Geriatr Psychiatry Neurol. 2000;13:60–4.
  • Rowland LP. Clinical aspects of sporadic ALS/MND. In: Shaw PJ, Strong MJ, editors. Motor neuron disorders. London: Butterworth-Heinemann; 2003, pp 111–41.
  • Tsuchiya K, Arai M, Matsuya S, Nishimura H, Ishiko T, Kondo H, et al. Sporadic amyotrophic lateral sclerosis resembling primary lateral sclerosis: report of an autopsy case and review of the literature. Neuropathology. 1999;19:71–6.
  • Sone M, Iwasaki Y, Kimura S, Ohkawa Y, Alba I, Yoshida M, et al. An autopsy case of ALS presenting marked degeneration of precentral gyrus, putamen and globus pallidus. Neuropathology. 2003;23:A40.
  • Kuipers-Upmeijer J, de Jager AE, Hew JM, Snoek JW, van Weerden TW. Primary lateral sclerosis: clinical, neurophy- siological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry. 2001;71:615–20.
  • Moretti P, Lieberman AP, Wilde EA, Giordani BI, Kluin KJ, Koeppe RA, et al. Novel insertional presenilin 1 mutation causing Alzheimer’s disease with spastic paraparesis. Neurology. 2004;62:1865–8.
  • Gordon PH, Katz IB, Pinto M, Kaufmann P, Mitsumoto H, Rowland LP. The natural history of primary lateral sclerosis. In preparation.
  • Fink JK. Progressive spastic paraparesis; hereditary spastic paraplegia and its relation to primary and amyotrophic lateral sclerosis. Semin Neurol. 2001;21:199–207.
  • Fink JK. The hereditary spastic paraplegias. Nine genes and counting. Arch Neurol. 2003;60:1045–9.
  • Fink JK. Hereditary spastic paraplegia; spastin phenotype and function. Arch Neurol. 2004;61:830–3.
  • Fink JK. Advances in hereditary spastic paraplegia. Exper Neurol. 2003;184:S100–6.
  • Tallaksen CME, Drr A, Brice A. Recent advances in hereditary spastic paraplegia. Curr Op Neurol. 2001;14:457–63.
  • Gelbard HA. Synpases and Sisyphus: life without para- plegin. J Clin Invest. 2004;113:185–7.
  • Reid E. Science in motion; common molecular pathological themes emerge in the hereditary spastic paraplegias. J Med Gene. 2003;40:81–6.
  • McDermott CJ, Grierson AJ, Wood JD, Bingley M, Wharton SB, Bushby KM, Shaw PJ. Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann Neurol. 2003;54:748–59.
  • Wharton SB, McDermott CJ, Grierson SJ, Wood JD, Gelsthorpe C, Ince PG, Shaw PJ. The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation in the spastin gene. J Neuropath Exp Neurol. 2003;62:1166–77.
  • Ferreirinha F, Quattrini A, Pirozzi M, et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest. 2004;113:231–42.
  • Shaw-Smith CJ, Lewis SJG, Reid E. X-linked adrenoleuko- dystrophy presenting as autosomal dominant pure hereditary spastic paraplegia. J Neurol Neurosurg. Psychiatry. 2004;75:686–8.
  • Tassin J, Drr A, Bonnet A-M, Gil R, Vidailhet M, Lucking CB, et al. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain. 2000;123:1112–21.
  • Furukawa Y, Graf WD, Wong H, Shimadzu M, Kish SJ. Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) mutations. Neurology. 2001;56:1121–4.
  • Ben Hamida M, Hentati F, Ben Hamida C. Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. Brain. 1990;113:347–63.
  • Gascon GG, Chavis P, Yaghmour A, Stigsby B, Shums A, Ozand P, Siddique T. Familial childhood primary lateral sclerosis with associated gaze paresis. Neuropediatrics. 1995;26:313–9.
  • Hentati A, Bejaoui K, Pericak-Vance MA, Hentati F, Speer MC, Hung WY, et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat Genet. 1994;7:425–8.
  • Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet. 2001;29:166–73.
  • Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet. 2001;29:160–5.
  • Eymard-Pierre E, Lesca G, Dollet S, Santorelli FM, di Capua M, Bertini E, Boespflug-Tanguy O. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet. 2002;71:518–27.(Epub 2002 Jul 26.)
  • Devon RS, Helm JR, Rouleau GA, Leitner Y, Lerman- Sagie T, Lev D, Hayden MR. The first nonsense mutation in alsin results in a homogeneous phenotype of infantile- onset ascending spastic paralysis with bulbar involvement in two siblings. Clin Genet. 2003;64:210–5.
  • Lesca G, Eymard-Pierre E, Santorelli FM, Cusmai R, Di Capua M, Valente EM, et al. Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families. Neurology. 2003;60:674–82.
  • Grunnet ML, Leicher C, Zimmerman A, Zalneraitis E, Barwick M. Primary lateral sclerosis in a child. Neurology. 1989;39:1530–2.
  • Chinnery PF, Keers SM, Holden MJ, Ramesh V, Dalton A. Infantile hereditary spastic paraparesis due to codominant mutations in the spastin gene. Neurology. 2004;63:710–2.
  • Yamanaka K, van de Velde C, Eymard-Pierre E, Bertini E, Boespflug-Tanguy O, Cleveland DW. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease. Proc Natl Acad Sci. USA. 2003; 100:16041–6.(Epub 2003 Dec 10.)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.